Cargando…
Moderne medikamentöse Therapie der interstitiellen Lungenerkrankung bei systemischer Sklerose
Systemic Sclerosis with Interstitial Lung Disease (SSc-ILD) is associated with an increased risk of morbidity and mortality. Because of a lack of approved medications that can effectively influence SSc-ILD disease course, there is a need for new therapeutic options. Treatment with immunomodulatory t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2021
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841211/ https://www.ncbi.nlm.nih.gov/pubmed/34861699 http://dx.doi.org/10.1055/a-1658-5176 |